Ruymara Candal Nogueira

Ruymara Candal Nogueira

Auto-generated profile, based on publicly available information

Ruymara Candal Nogueira

Faculdade Multivix, Brasil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Jornal Vascular Brasileiro
Verified
Journal Article
Open access
ACAnita dos Santos Cardoso
Anita dos Santos Cardoso
YMYago Marcelino Maciel
Yago Marcelino Maciel
RNRuymara Candal Nogueira
Ruymara Candal Nogueira
RMRafaela Tezza Matiola
Rafaela Tezza Matiola
TRThais Pereira da Rosa
Thais Pereira da Rosa
BPBrunella Flores Pupo
Brunella Flores Pupo
Eagle Syndrome (ES), characterized by elongation of the styloid process (ESP), is a rare condition with diverse symptoms. Among its complications, carotid dissection is a significant outcome requiring accurate diagnosis and intervention. This study describes a case of bilateral carotid dissection associated with ES, emphasizing diagnostic challenges, management, and therapeutic approaches. Conducted under Research Ethics Committee protocol 68193123.5.0000.0119 and approval number 6.028.970, it reports on a 38-year-old woman with a 5-day history of left-sided headache, otalgia, syncope, right-hand limitation, and visual blurring. MRI revealed left carotid bulb occlusion and recent ischemic events, while angio-CT confirmed bilateral carotid dissections. After clinical management failed, an intraoral surgical approach was chosen, resulting in full neurological recovery. CT confirmed ESP, and genetic testing was negative. This case highlights the need to consider ES in atypical cervicofacial symptoms, given its underdiagnosed incidence (~4% for ESP; ~0.16% for ES), reinforcing the importance of better clinical guidelines.

10 January 2024 in Cuadernos de Educación y Desarrollo
Verified
Journal Article
Open access
PDF file
RNRuymara Candal Nogueira
Ruymara Candal Nogueira
MMMarina Machado De Melo
Marina Machado De Melo
ECEmilly da Silva Dela Costa
Emilly da Silva Dela Costa
MMMariana Frederico De Moura
Mariana Frederico De Moura
HCHigor Braga Cartaxo
Higor Braga Cartaxo
A gestação é considerada um período de constantes mudanças e transformações fisiológicas, emocionais, sociais e psicológicas. O aleitamento concretiza o vínculo de mãe e filho no puerpério, trazendo benefícios nutritivos e psicológicos a ambos. De acordo com estudos mundiais apenas 16% praticam aleitamento materno exclusivo (AME). A qualidade da amamentação é pior em países subdesenvolvidos, de forma que apenas 2 de cada 10 crianças recebem AME. Fatores inerentes para mãe e/ou o bebê podem estar relacionados com a interrupção precoce do aleitamento materno, um desses fatores é a depressão pós-parto (DPP).

1 February 2024 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
MMMaria Vitória Frota Magalhães
Maria Vitória Frota Magalhães
RNRuymara Candal Nogueira
Ruymara Candal Nogueira
JBJoana Baschung Bertazzon
Joana Baschung Bertazzon
AVAndressa Gonçalves Vicente
Andressa Gonçalves Vicente
MSMarcos Gabriel Bastos Sereno
Marcos Gabriel Bastos Sereno
MSMarina Rodrigues e Silva
Marina Rodrigues e Silva
Objective: To analyze therapeutic evidence regarding the potential antioxidant, anti-inflammatory and neuroprotective effects of cannabidiol (CBD) and its effectiveness for the treatment of Alzheimer's Disease (AD). Methodology: Data collection, in the Virtual Health Library, targeting the primary databases Medical Literature Analysis and Retrieval System Online (Medline) and Latin American and Caribbean Literature in Health Sciences (Lilacs) to answer the research question: is the therapeutic use of cannabidiol effective in improving the treatment of patients with Alzheimer's Disease? Results: 14 articles were selected, after analyzing the inclusion and exclusion criteria, all after 2017, with the largest number concentrating on systematic literature review or meta-analysis. Conclusion: Cannabidiol has clear potential to reduce the symptoms of AD given its action on the Central Nervous System. Therefore, its therapeutic use in the treatment of AD emerges as a promising field of investigation, highlighting its relevance as a safe and effective treatment option. Therefore, an in-depth understanding of the antioxidant, anti-inflammatory and neuroprotective properties of CBD is necessary, not only for a better clinical definition of AD, but also for a series of neurological diseases that still have undefined treatments. The potential of CBD, therefore, represents a valuable alternative in the context of neurology, offering significant perspectives for the treatment of neurodegenerative conditions.